Cargando…
Metformin: A promising drug for human cancers
Small-molecule chemical drugs are of great significance for tumor-targeted and individualized therapies. However, the development of new small-molecule drugs, from basic experimental research and clinical trials to final application in clinical practice, is a long process that has a high cost. It ta...
Autores principales: | Wu, Hongnian, Huang, Dan, Zhou, Hong, Sima, Xueqin, Wu, Zhe, Sun, Yanling, Wang, Long, Ruan, Ying, Wu, Qian, Wu, Feng, She, Tonghui, Chu, Ying, Huang, Qizhi, Ning, Zhifeng, Zhang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178677/ https://www.ncbi.nlm.nih.gov/pubmed/35720480 http://dx.doi.org/10.3892/ol.2022.13325 |
Ejemplares similares
-
ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
por: Wei, Yaolu, et al.
Publicado: (2022) -
Metformin and the promise of geroprotection
por: Kalra, Sanjay, et al.
Publicado: (2012) -
Cancer stem cells in esophageal squamous cell cancer
por: Wu, Qian, et al.
Publicado: (2019) -
Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023) -
Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy
por: Zhu, Xiaoyi, et al.
Publicado: (2021)